Until recently, GLP-1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World Obesity Federation, a charity, reckons that two-thirds of the world’s 1bn obese ...
This comes as the broader job market is in what some analysts have described as a “no-hire, no fire” standstill, with many ...